AD patients have been found to exhibit persistent and excessive activation of immune cells, potentially leading to the build-up of Aβ and tau, loss of synapses, disruption of the blood-brain barrier (BBB), and neurodegeneration [24]. This evidence concerns the gene MAPT and Alzheimer disease.